Refine by
In Vivo Models Articles & Analysis
25 articles found
The advent of organoid technology has transformed biomedical research through the development of 3D models that precisely replicate human organ structures and functions in a physiological context. ...
These cell lines serve as essential models for studying the biology of colorectal cancer, testing new therapies, and exploring the mechanisms of drug resistance. ...
Types of ADME Testing Services To ensure comprehensive evaluation, various testing methodologies are employed, including in vitro and in vivo studies, alongside computational modeling techniques. In vitro tests often involve using cell cultures or biological fluids to assess how drugs are absorbed and metabolized. These preliminary studies can provide rapid ...
When studied in living organisms, this relationship is referred to as in vivo PK/PD, a discipline that provides invaluable insights into drug behavior within a biological context. ...
Cancer is a worldwide disease and one of the leading causes of morbidity and mortality today. Traditionally, mouse models have been used for research as in vivo model organisms. However, the zebrafish (Danio rerio), also known as zebrafish, has emerged as an important new cancer model due to its small size, brood weight, and ...
Precision-Cut Lung Slices (PCLS) have emerged as a innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses. By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in ...
Determine Cytotoxicity and EfficacyEvaluating the toxicity and killing effects of ADC on target cancer cells through in vitro and in vivo models is a key step in verifying its efficacy. These tests can help determine effective doses and potential side effects, thereby guiding the design of clinical trials.4. ...
Applicability of Animal ModelsIn the process of antibody discovery, the use of in vivo models is often limited by the applicability of animal models, which can cause trouble for early development and subsequent testing. ...
The complexity and diversity of these conditions necessitate the development of detailed medical models for a comprehensive understanding of the diseases. Over time, Type 1 and Type 2 Diabetes Mellitus Models, Metabolic Disease Models, and generalized Diabetes Models have become integral to diabetes research and treatment ...
Numerous studies employing syngeneic and spontaneous tumor models have demonstrated that genetic deletion or pharmacological inhibition of CD73 or A2AR significantly reduces tumor growth and metastasis. ...
AdvaitaBio’s IPathwayGuide plays significant role in the research of a Stanford investigator. Stanford University is one of the world’s leading research and teaching institutions. With a 1.69 billion dollar annual sponsored research budget, Stanford has been delivering breakthrough discoveries in numerous domains. For over 6 years, Dr. Linda Yip has been conducting research at ...
The same resistance pattern was found in knockout mouse models in vivo. Further studies of other solid tumor types, including pancreatic, ovarian, and lung cell lines, showed the same results: the resistance to CAR-T cell therapy stems from the loss of interferon pathway genes. ...
The strategy to support "first-come" sequential combination therapy with anticancer targeted drugs is currently obtained in in vitro cell models and needs to be further validated in in vivo animal models. Represented by the BRAF-V600E/KEAP1 neoPPI, studies combining validation and transformation of molecular mechanisms unique to such tumors ...
Nonetheless, the next step in developing new bacteriocin-based therapeutics involves the use of in vivo models. The antibacterial and/or toxic effects of bacteriocins have been studied in mouse models and the latest alternative animal models, such as drosophila, zebrafish embryos, roundworms, wax moths or brine shrimp. ...
We have demonstrated the suitability of this bone graft substitute both in in-vitro and in-vivo models. In the in-vitro model, rhBMP-2 release was sustained for 28 days. In the in-vivo animal studies, the bone graft substitute showed both osteoinductive potential with ectopic bone formation in a rat muscle pouch, as well as ...
Both current in vitro and in vivo models used in the development of candidate therapies for the treatment of intestinal diseases have severe limitations. ...
Monolayer cultures of Caco-2 cells, a commonly used human colorectal tumor cell line, are not capable of replicating this complexity. While animal models possess system complexity, it is frequently difficult to modulate and control the desired experimental parameters in in vivo studies. ...
Due to a lack of robust in vivo gut models, animal studies are generally required to evaluate gut toxicity. ...
The AD-induced in vivo mouse model was performed as previously described with minor modifications (Kang et al., 2015). ...
Active PDE then hydrolyzes antiinflammatory cAMP to facilitate inflammatory signaling. To test this model in vivo, we mutated the integrin binding site of PDE4D5 in mice. This mutation reduced endothelial inflammatory activation in atherosclerosis-prone regions of arteries and, in a hyperlipidemia model, reduced atherosclerotic plaque size while ...